Ulf Landmesser

Ulf Landmesser publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ulf Landmesser sits on this spectrum.

Ulf Landmesser D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ulf Landmesser sits on this spectrum.

Overview

Best Publications

• 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)

  Marco Roffi;Carlo Patrono;Jean-Philippe Collet;Christian Mueller

  7212
  Citations

• 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

  François Mach;Colin Baigent;Alberico L Catapano;Konstantinos C Koskinas

  7143
  Citations

• [2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation].

  Marco Roffi;Carlo Patrono;Jean-Philippe Collet;Christian Mueller

  6382
  Citations

• 2014 ESC/EACTS guidelines on myocardial revascularization.

  Stephan Windecker;Philippe Kolh;Fernando Alfonso;Jean-Philippe Collet

  5652
  Citations

• 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

  Alberico L. Catapano;Ian Graham;Guy De Backer;Olov Wiklund

  4084
  Citations

• 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

  Frank L J Visseren;François Mach;Yvo M Smulders;David Carballo

  3938
  Citations

• 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

  Stephan Windecker;Philippe Kolh;Fernando Alfonso;Jean-Philippe Collet

  3771
  Citations

• 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

  Marco Valgimigli;Héctor Bueno;Robert A Byrne;Jean-Philippe Collet

  3116
  Citations

• 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

  Marco Valgimigli;Héctor Bueno;Robert A. Byrne;Jean-Philippe Collet

  2189
  Citations

• Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

  Ulf Landmesser;Sergey Dikalov;S. Russ Price;Louise McCann

  2017
  Citations

• Role of oxidative stress in atherosclerosis

  David Harrison;Kathy K Griendling;Ulf Landmesser;Burkhard Hornig

  1689
  Citations

• 2020 ESC Guidelines for the management of adult congenital heart disease.

  Helmut Baumgartner;Julie De Backer;Sonya V Babu-Narayan;Werner Budts

  1518
  Citations

• Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

  Jan Borén;M. John Chapman;M. John Chapman;Ronald M. Krauss;Chris J. Packard

  1470
  Citations

• 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).

  Alberico L. Catapano;Ian Graham;Guy De Backer;Olov Wiklund

  1283
  Citations

• Endothelial Function A Critical Determinant in Atherosclerosis

  Ulf Landmesser;Burkhard Hornig;Helmut Drexler

  1219
  Citations

• A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy

  Denise Hilfiker-Kleiner;Karol Kaminski;Edith Podewski;Tomasz Bonda

  1049
  Citations

• Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol.

  Kausik K Ray;Ulf Landmesser;Lawrence A Leiter;David Kallend

  1008
  Citations

• The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society.

  Charalambos Vlachopoulos;Panagiotis Xaplanteris;Victor Aboyans;Marianne Brodmann

  732
  Citations

• Vascular Oxidative Stress and Endothelial Dysfunction in Patients With Chronic Heart Failure Role of Xanthine-Oxidase and Extracellular Superoxide Dismutase

  Ulf Landmesser;Stephan Spiekermann;Sergey Dikalov;Helma Tatge

  705
  Citations

• ROLE OF P47(PHOX) IN VASCULAR OXIDATIVE STRESS AND HYPERTENSION CAUSED BY ANGIOTENSIN II

  Ulf Landmesser;Hua Cai;Sergey Dikalov;Louise McCann

  678
  Citations